Induction of Potent Humoral and Cell-Mediated Immune Responses Following Direct Injection of DNA Encoding the HIV Type 1 env and rev Gene Products

No abstract is available for this paper.

• Publication year

  1995

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  1995-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/aid.1995.11.933PMID 7492440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of HIV‐1 Nef‐specific cytotoxic T lymphocytes by Nef‐expressing DNA vaccine

  1996cited by this paper
• Immunogenic potential of rgp120 from African HIV-1 subtype A.

  1996cited by this paper
• A serologic analysis and the amino acid sequence of the V3 region of human immunodeficiency virus from carriers in Bangkok.

  1994cited by this paper
• Induction of Antigen-Specific Killer T Lymphocyte Responses Using Subunit SIVmac251 gag and env Vaccines Containing QS-21 Saponin Adjuvant

  1994cited by this paper
• Semiquantitative, Nonradioactive RT-PCR Detection of Immunoglobulin mRNA in Human B Cells and Plasma Cells

  1994cited by this paper
• Evidence of three HIV-1 subtypes in subgroups of individuals in Thailand.

  1994cited by this paper
• Gene inoculation generates immune responses against human immunodeficiency virus type 1.

  1993cited by this paper
• Direct Gene Transfer into Skeletal Muscle In Vivo: Factors Affecting Efficiency of Transfer and Stability of Expression

  1993cited by this paper
• Strong immunogenicity of a multicomponent peptide vaccine developed with the branched lysine oligopeptide method for human immunodeficiency virus infection

  1993cited by this paper
• Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease

  1993cited by this paper
• Examination of Parameters Affecting the Elicitation of Humoral Immune Responses by Particle Bombardment-Mediated Genetic Immunization

  1993cited by this paper
• Strong synergistic effects of multicomponent vaccine for human immunodeficiency virus infection.

  1993cited by this paper
• DNA Inoculation Induces Neutralizing Immune Responses Against Human Immunodeficiency Virus Type 1 in Mice and Nonhuman Primates

  1993influential reference
• A strategy for prophylactic vaccination against HIV.

  1993cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells.

  1993cited by this paper
• Molecular Cloning, Expression, and Biological Characterization of an HTLV-II Envelope Glycoprotein: HIV-1 Expression Is Permissive for HTLV-II-Induced Cell Fusion

  1993cited by this paper
• Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells.

  1992cited by this paper
• Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

  1992cited by this paper
• Six strains of human immunodeficiency virus type 1 isolated in Japan and their molecular phylogeny

  1992cited by this paper
• Galactose oxidation in the design of immunogenic vaccines.

  1992cited by this paper
• Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.

  1992cited by this paper
• CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope

  1992cited by this paper
• The Role of anticodon bases and the discriminator nucleotide in the recognition of some E. coli tRNAs by their aminoacyl-tRNA synthetases

  1992cited by this paper
• Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex

  1992cited by this paper
• Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.

  1991cited by this paper
• Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

  1991cited by this paper
• The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.

  1991cited by this paper
• Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41 [published erratum appears in J Exp Med 1992 Feb 1;175(2):621]

  1991cited by this paper
• Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals.

  1991cited by this paper
• Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected].

  1991cited by this paper
• Serum antibody directed against synthetic peptides derived from HIV-1 protein sequence obtained from 26 Japanese HIV-1-infected individuals.

  1991cited by this paper
• Induction of CD8+ cytotoxic T-cells by immunization with purified HIV-1 envelope protein in ISCOMs.

  1991cited by this paper
• Mutational definition of the human immunodeficiency virus type 1 Rev activation domain

  1991cited by this paper
• Exposure to Human Immunodeficiency Virus Type I-Specific T Helper Cell Responses before Detection of Infection by Polymerase Chain Reaction and Serum Antibodies

  1991cited by this paper
• The Safety and Immunogenicity of a Human Immunodeficiency Virus Type 1 (HIV-1) Recombinant gp160 Candidate Vaccine in Humans

  1991cited by this paper
• Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.

  1991cited by this paper
• A human cell factor is essential for HIV‐1 Rev action.

  1990cited by this paper
• HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals.

  1990cited by this paper
• Direct gene transfer into mouse muscle in vivo.

  1990influential reference
• Cell type-specific expression of transforming growth factor-beta 1 in the mouse uterus during the periimplantation period.

  1990cited by this paper
• Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV.

  1990cited by this paper
• Immune response and epitope mapping of a candidate hiv‐1 p17 vaccine hgp30

  1990cited by this paper
• Studies of cloned simian immunodeficiency virus-specific T lymphocytes. gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificity.

  1990cited by this paper
• Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

  1990cited by this paper
• Prospects for a vaccine against HIV

  1989cited by this paper
• Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.

  1989cited by this paper
• Prospects for prevention of and early intervention against HIV.

  1989cited by this paper
• Development and testing of AIDS vaccines.

  1988cited by this paper
• Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.

  1988cited by this paper
• Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes

  1988cited by this paper
• Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization.

  1988cited by this paper
• Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds.

  1988cited by this paper
• Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.

  1987cited by this paper
• Histochemical staining of clonal mammalian cell lines expressingE. coliβ galactosidase indicates heterogeneous expression of the bacterial gene

  1987cited by this paper
• CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.

  1986cited by this paper
• HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.

  1986cited by this paper
• Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

  1986cited by this paper
• A second post-transcriptional trans-activator gene required for HTLV-III replication

  1986cited by this paper
• Complete nucleotide sequence of the AIDS virus, HTLV-III

  1985cited by this paper
• Delayed‐Type Hypersensitivity to Hen Egg‐White Lysozyme: I. The Surface Phenotypes of Suppressor T Cells Induced by Intravenous Injection of Lysozyme‐Modified Spleen Cells, and Their Moleculor Interactions

  1982cited by this paper
• Delayed-type hypersensitivity to hen egg-white lysozyme. I. The surface phenotypes of suppressor T cells induced by intravenous injection of lysozyme-modified spleen cells, and their molecular interactions.

  1982cited by this paper
• Genetic control of immune response to sperm whale myoglobin in mice. II. T lymphocyte proliferative response to the synthetic antigenic sites.

  1979cited by this paper
• Genetic Control of Immune Response to Sperm Whale Myoglobin in Mice

  1978cited by this paper

• In Silico and in Vivo Analysis of HIV-1 Rev Regulatory Protein for Evaluation of a Multiepitope-based Vaccine Candidate

  2021cites this paper
• Attenuated Listeria monocytogenes as a Vaccine Vector for the Delivery of OMPW, the Outer Membrane Protein of Aeromonas hydrophila

  2020cites this paper
• Evaluation of HIV-1 Regulatory and Structural Proteins as Antigen Candidate in Mouse and Human.

  2020cites this paper
• Application of Plasmid Engineering to Enhance Yield and Quality of Plasmid for Vaccine and Gene Therapy

  2019cites this paper
• Explorer Increased immune response elicited by DNA vaccination with a synthetic gp 120 sequence with optimized codon usage

  2017cites this paper
• A peptide-based nanofibrous hydrogel as a promising DNA nanovector for optimizing the efficacy of HIV vaccine.

  2014cites this paper
• DNA Vaccines for Infectious Diesase

  2011cites this paper
• Current progress in the development of a prophylactic vaccine for HIV-1

  2010cites this paper
• β-Glucan Oligosaccharide Enhances CD8+ T Cells Immune Response Induced by a DNA Vaccine Encoding Hepatitis B Virus Core Antigen

  2010cites this paper
• Coxsackievirus B3 infection promotes generation of myeloid dendritic cells from bone marrow and accumulation in the myocardium.

  2009cites this paper
• The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection.

  2007cites this paper
• Candidate HIV-1 Tat vaccine development: from basic science to clinical trials.

  2006cites this paper
• From Plasmids to Protection: A Review of DNA Vaccines Against Infectious Diseases

  2006cites this paper
• A tale of two clades: monkeypox viruses.

  2005cites this paper
• Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies.

  2005cites this paper
• Bacterial toxins: potential weapons against HIV infection.

  2005cites this paper
• Macrophage inflammatory protein‐1α expression plasmid enhances DNA vaccine‐induced immune responses against HSV‐2

  2005cites this paper
• Construction and expression of a Rev-dependent TNF-R1 expressing HIV-infected-cell injurious vectors.

  2005cites this paper
• Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.

  2004cites this paper
• Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.

  2004cites this paper
• DNA gene vaccination for HIV

  2004cites this paper
• Strategies of gene and immune therapy for tumors and viral diseases

  2003cites this paper
• Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d

  2003cites this paper
• Chitin Micro-Particles (CMP): A Useful Adjuvant for Inducing Viral Specific Immunity when Delivered Intranasally with an HIV-DNA Vaccine

  2003cites this paper
• Plasmid Immunization Primes Unique DTH Responses to HIV-1MN Envelope Epitopes as Compared to Recombinant Protein Vaccination

  2002cites this paper
• Nucleic Acid Vaccination against HIV-1

  2002cites this paper
• Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine.

  2002cites this paper
• Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.

  2002cites this paper
• Immunologic characterization of HIV-specific DNA vaccine.

  2001cites this paper
• Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.

  2001cites this paper
• Enhanced Avidity Maturation of Antibody to Human Immunodeficiency Virus Envelope: DNA Vaccination with gp120–C3d Fusion Proteins

  2001cites this paper
• A Novel Recombinant Adeno-Associated Virus Vaccine Induces a Long-Term Humoral Immune Response to Human Immunodeficiency Virus

  2001cites this paper
• Detection of Progeny Immune Responses after Intravenous Administration of DNA Vaccine to Pregnant Mice

  2001cites this paper
• Development of disabled, replication-defective gene transfer vectors from the Jembrana disease virus, a new infectious agent of cattle.

  2001cites this paper
• Human Immunodeficiency Virus Type 1-Specific Immunity after Genetic Immunization Is Enhanced by Modification of Gag and Pol Expression

  2001cites this paper
• Rapid and Wide-Reaching Delivery of HIV-1 env DNA Vaccine by Intranasal Administration

  2001influential citation
• Protection against influenza virus challenge by topical application of influenza DNA vaccine.

  2001cites this paper
• Transplacental Genetic Immunization After Intravenous Delivery of Plasmid DNA to Pregnant Mice1

  2001cites this paper
• Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type‐1 through the activation of complement system

  2001cites this paper
• Activation of HIV‐1‐specific immune responses to an HIV‐1 vaccine constructed from a replication‐defective adenovirus vector using various combinations of immunization protocols

  2001cites this paper
• Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene.

  2001cites this paper
• Response Induced by an HIV-1-Specific DNA Administration Influences the Th 1 / Th 2 The Timing of GM-CSF Expression Plasmid Klinman and

  2000cites this paper
• Cytokine fusion constructs as DNA vaccines against tumors.

  2000cites this paper
• Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses.

  2000cites this paper
• Th1‐biased immune responses induced by DNA‐based immunizations are mediated via action on professional antigen‐presenting cells to up‐regulate IL‐12 production

  2000cites this paper
• The Timing of GM-CSF Expression Plasmid Administration Influences the Th1/Th2 Response Induced by an HIV-1-Specific DNA Vaccine1

  2000cites this paper
• 8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine

  2000cites this paper
• Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina.

  2000cites this paper
• Cytokine and costimulatory factor-encoding plasmids as adjuvants for DNA vaccination.

  2000cites this paper
• HIV-DNA Vaccination Following Transfer of a Large Number of Activated T Cells Enhances Immunoresponses Against HIV-1

  2000cites this paper
• A critical examination of current HIV therapies.

  2000cites this paper
• Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1.

  1999cites this paper
• Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity.

  1999cites this paper
• IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine.

  1999cites this paper
• Genes That Induce Immunity—DNA Vaccines

  1999cites this paper
• Genetic Live Vaccines Mimic the Antigenicity But Not Pathogenicity of Live Viruses

  1999cites this paper
• Evaluation of Novel Human Immunodeficiency Virus Type 1 Gag DNA Vaccines for Protein Expression in Mammalian Cells and Induction of Immune Responses

  1999cites this paper
• Immunomodulatory effect of a plasmid expressing CD40 ligand on DNA vaccination against human immunodeficiency virus type‐1

  1999cites this paper
• Immune responses to DNA vaccines

  1999cites this paper
• Inhibition of PHA-induced cell proliferation by polyclonal CD4 antibodies generated by DNA immunization.

  1999cites this paper
• DNA inoculations with HIV-1 recombinant genomes that express cytokine genes enhance HIV-1 specific immune responses.

  1999cites this paper
• DNA vaccines: technology and application as anti-parasite and anti-microbial agents.

  1999cites this paper
• Nucleic acid immunization: concepts and techniques associated with third generation vaccines.

  1999cites this paper
• Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial.

  1999cites this paper
• Attempt to modify the immune response developed against FIV gp120 protein by preliminary FIV DNA injection.

  1999cites this paper
• DNA inoculation with a plasmid vector carrying the faeG adhesin gene of Escherichia coli K88ab induced immune responses in mice and pigs.

  1999cites this paper
• DNA vaccines for viral diseases.

  1999cites this paper
• Macrophage inflammatory protein‐1α (MIP‐1α) expression plasmid enhances DNA vaccine‐induced immune response against HIV‐1

  1999cites this paper
• Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen.

  1998cites this paper
• Adjuvant effect of Ubenimex on a DNA vaccine for HIV‐1

  1998cites this paper
• The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants.

  1998cites this paper
• Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage

  1998cites this paper
• DNA Immunization of Mice against SIVmac239 Gag and Env Using Rev-Independent Expression Plasmids

  1998cites this paper
• DNA Vaccination/Genetic Vaccination

  1998cites this paper
• First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.

  1998cites this paper
• Nucleic acid-based vaccines as an approach to immunization against human immunodeficiency virus type-1.

  1998cites this paper
• Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts.

  1998cites this paper
• Intranasal administration of human immunodeficiency virus type‐1 (HIV‐1) DNA vaccine with interleukin‐2 expression plasmid enhances cell‐mediated immunity against HIV‐1

  1998cites this paper
• Induction of Systemic and Mucosal Immune Responses to Human Immunodeficiency Virus Type 1 by a DNA Vaccine Formulated with QS-21 Saponin Adjuvant via Intramuscular and Intranasal Routes

  1998cites this paper
• Comparison of Intranasal and Intramuscular Immunization against Human Immunodeficiency Virus Type 1 with a DNA-Monophosphoryl Lipid A Adjuvant Vaccine

  1998cites this paper
• Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethylcellulose, augments mucosal antibody production and cell-mediated immune response.

  1998cites this paper
• Comparative Analysis of Humoral Immune Responses to HIV Type 1 Envelope Glycoproteins in Mice Immunized with a DNA Vaccine, Recombinant Semliki Forest Virus RNA, or Recombinant Semliki Forest Virus Particles

  1998cites this paper
• Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1

  1997cites this paper
• Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.

  1997cites this paper
• DNA vaccines.

  1997cites this paper
• Genes synthetiques du vih

  1997cites this paper
• HIV‐1‐specific cell‐mediated immune responses induced by DNA vaccination were enhanced by mannan‐coated liposomes and inhibited by anti‐interferon‐γ antibody

  1997cites this paper
• DNA vaccines for immunodeficiency viruses.

  1997cites this paper
• Human immunodeficiency virus type‐1‐specific immune responses induced by DNA vaccination are greatly enhanced by mannan‐coated diC14‐amidine

  1997cites this paper
• Induction of HIV‐1 Specific Mucosal Immune Responses by DNA Vaccination

  1997cites this paper
• Strong augment effect of IL-12 expression plasmid on the induction of HIV-specific cytotoxic T lymphocyte activity by a peptide vaccine candidate.

  1997cites this paper
• Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope

  1997cites this paper
• HIV-1 Env glycoproteins from two series of primary isolates: replication phenotype and immunogenicity.

  1997cites this paper
• Gene gun‐based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV

  1997cites this paper
• Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes

  1997influential citation
• Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12.

  1997cites this paper
• DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity.

  1997cites this paper
• Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination

  1997cites this paper
• Do DNA Vaccines Induce Autoimmune Disease?

  1997cites this paper
• Induction of Neutralizing Antibodies Against HTLV-I Envelope Proteins After Combined Genetic and Protein Immunizations in Mice

  1997cites this paper